 <h1>Panhematin Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>hemin</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about hemin. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Panhematin.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to hemin: intravenous powder for solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, hemin (the active ingredient contained in Panhematin) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking hemin:</p><p>
<i>Less common</i>
</p><ul>
<li>Bluish color</li>
<li>changes in skin color</li>
<li>fever</li>
<li>itching, pain, redness, swelling, tenderness, or warmth on the skin</li>
<li>redness or pain at the catheter site</li>
<li>swelling of the foot or leg tenderness</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Back pain</li>
<li>black, tarry stools</li>
<li>bleeding gums</li>
<li>blood in the urine or stools</li>
<li>dark urine</li>
<li>decreased urination</li>
<li>dizziness</li>
<li>fainting</li>
<li>fever</li>
<li>irregular heartbeat</li>
<li>lightheadedness</li>
<li>pinpoint red spots on the skin</li>
<li>stomach pain</li>
<li>tiredness</li>
<li>unusual bleeding or bruising</li>
<li>yellow eyes or skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of hemin may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Headache</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Rash</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Dry, red, hot, or irritated skin</li>
</ul><p>
<!-- end intravenous powder for solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to hemin: intravenous powder for injection</i></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Poor venous access</p>
<p><b>Postmarketing reports</b>: Thrombocytopenia, coagulopathy (including prolonged prothrombin time and prolonged partial thromboplastin time), hemolysis<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (0.01% to 0.1%): Anaphylactoid reaction, hypersensitivity (e.g., dermatitis medicamentosa, tongue edema)<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Cellulitis<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Phlebitis/injection site phlebitis, catheter-related complication (e.g., erythema, pain, bleeding, extravasation, infusion site swelling)<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Increased serum ferritin</p>
<p><b>Frequency not reported</b>: Blood creatinine increased</p>
<p><b>Postmarketing reports</b>: Iron overload<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Postmarketing reports</b>: Reversible renal shutdown (after administration of excessive doses)<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Phlebitis (with or without leukocytosis and with or without mild pyrexia has occurred after administration of this drug through small arm veins)<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Frequency not reported</b>: Skin discoloration<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Panhematin (hemin)." Recordati Rare Diseases Inc, Lebanon, NJ. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Panhematin (hemin)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>1 Review</li>
<li>Drug class: miscellaneous uncategorized agents</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Panhematin &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Porphyria</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to hemin: intravenous powder for injection</i></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Poor venous access</p><p><b>Postmarketing reports</b>: Thrombocytopenia, coagulopathy (including prolonged prothrombin time and prolonged partial thromboplastin time), hemolysis<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (0.01% to 0.1%): Anaphylactoid reaction, hypersensitivity (e.g., dermatitis medicamentosa, tongue edema)<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Cellulitis<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Phlebitis/injection site phlebitis, catheter-related complication (e.g., erythema, pain, bleeding, extravasation, infusion site swelling)<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Increased serum ferritin</p><p><b>Frequency not reported</b>: Blood creatinine increased</p><p><b>Postmarketing reports</b>: Iron overload<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Postmarketing reports</b>: Reversible renal shutdown (after administration of excessive doses)<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Phlebitis (with or without leukocytosis and with or without mild pyrexia has occurred after administration of this drug through small arm veins)<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Frequency not reported</b>: Skin discoloration<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Panhematin (hemin)." Recordati Rare Diseases Inc, Lebanon, NJ. </p><h2>More about Panhematin (hemin)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Español</li>
<li>1 Review</li>
<li>Drug class: miscellaneous uncategorized agents</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Panhematin &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Porphyria</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>